tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amneal announces FDA approval of cyclosporine ophthalmic emulsion 0.05%
PremiumThe FlyAmneal announces FDA approval of cyclosporine ophthalmic emulsion 0.05%
16d ago
Amneal Pharmaceuticals announces FDA approval for iohexol injection
Premium
The Fly
Amneal Pharmaceuticals announces FDA approval for iohexol injection
1M ago
Amneal Pharmaceuticals Reports Strong Q3 Growth Amid Challenges
Premium
Company Announcements
Amneal Pharmaceuticals Reports Strong Q3 Growth Amid Challenges
2M ago
Amneal Pharmaceuticals raises 2025 adjusted EPS view to 75c-80c from 70c-75c
PremiumThe FlyAmneal Pharmaceuticals raises 2025 adjusted EPS view to 75c-80c from 70c-75c
2M ago
Amneal gets FDA approval for beclomethasone dipropionate HFA inhalation aerosol
Premium
The Fly
Amneal gets FDA approval for beclomethasone dipropionate HFA inhalation aerosol
2M ago
Mycophenolate Pregnancy Registry: Key Insights for Investors
Premium
Company Announcements
Mycophenolate Pregnancy Registry: Key Insights for Investors
2M ago
Amneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages
PremiumRatingsAmneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages
3M ago
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
Premium
The Fly
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
3M ago
Amneal Pharmaceuticals price target raised to $14 from $12 at JPMorgan
Premium
The Fly
Amneal Pharmaceuticals price target raised to $14 from $12 at JPMorgan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100